These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 32292562)

  • 1. Implementation of the CYP Index for the Design of Selective Tryptophan-2,3-dioxygenase Inhibitors.
    Parr BT; Pastor R; Sellers BD; Pei Z; Jaipuri FA; Castanedo GM; Gazzard L; Kumar S; Li X; Liu W; Mendonca R; Pavana RK; Potturi H; Shao C; Velvadapu V; Waldo JP; Wu G; Yuen PW; Zhang Z; Zhang Y; Harris SF; Oh AJ; DiPasquale A; Dement K; La H; Goon L; Gustafson A; VanderPorten EC; Mautino MR; Liu Y
    ACS Med Chem Lett; 2020 Apr; 11(4):541-549. PubMed ID: 32292562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-throughput fluorescence-based screening assays for tryptophan-catabolizing enzymes.
    Seegers N; van Doornmalen AM; Uitdehaag JC; de Man J; Buijsman RC; Zaman GJ
    J Biomol Screen; 2014 Oct; 19(9):1266-74. PubMed ID: 24870017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of Tryptophan-Dioxygenase Activity Increases the Antitumor Efficacy of Immune Checkpoint Inhibitors.
    Schramme F; Crosignani S; Frederix K; Hoffmann D; Pilotte L; Stroobant V; Preillon J; Driessens G; Van den Eynde BJ
    Cancer Immunol Res; 2020 Jan; 8(1):32-45. PubMed ID: 31806638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heme-containing enzymes and inhibitors for tryptophan metabolism.
    Yan D; Lin YW; Tan X
    Metallomics; 2017 Sep; 9(9):1230-1240. PubMed ID: 28650043
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Yang D; Zhang S; Fang X; Guo L; Hu N; Guo Z; Li X; Yang S; He JC; Kuang C; Yang Q
    J Med Chem; 2019 Oct; 62(20):9161-9174. PubMed ID: 31580660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypothesis: Metabolic targeting of 5-aminolevulinate synthase by tryptophan and inhibitors of heme utilisation by tryptophan 2,3-dioxygenase as potential therapies of acute hepatic porphyrias.
    Badawy AA
    Med Hypotheses; 2019 Oct; 131():109314. PubMed ID: 31443750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dexamethasone Induces the Expression and Function of Tryptophan-2-3-Dioxygenase in SK-MEL-28 Melanoma Cells.
    Cecchi M; Paccosi S; Silvano A; Eid AH; Parenti A
    Pharmaceuticals (Basel); 2021 Mar; 14(3):. PubMed ID: 33806305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitrobenzofurazan derivatives of N'-hydroxyamidines as potent inhibitors of indoleamine-2,3-dioxygenase 1.
    Paul S; Roy A; Deka SJ; Panda S; Trivedi V; Manna D
    Eur J Med Chem; 2016 Oct; 121():364-375. PubMed ID: 27267006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery and preliminary structure-activity relationship of 1H-indazoles with promising indoleamine-2,3-dioxygenase 1 (IDO1) inhibition properties.
    Qian S; He T; Wang W; He Y; Zhang M; Yang L; Li G; Wang Z
    Bioorg Med Chem; 2016 Dec; 24(23):6194-6205. PubMed ID: 27769672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The potential of targeting indoleamine 2,3-dioxygenase for cancer treatment.
    Gostner JM; Becker K; Überall F; Fuchs D
    Expert Opin Ther Targets; 2015 May; 19(5):605-15. PubMed ID: 25684107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indoleamine 2,3-dioxygenase 1 deficiency attenuates CCl4-induced fibrosis through Th17 cells down-regulation and tryptophan 2,3-dioxygenase compensation.
    Zhong W; Gao L; Zhou Z; Lin H; Chen C; Huang P; Huang W; Zhou C; Huang S; Nie L; Liu Y; Chen Y; Zhou D; Lv Z
    Oncotarget; 2017 Jun; 8(25):40486-40500. PubMed ID: 28465467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery and Characterisation of Dual Inhibitors of Tryptophan 2,3-Dioxygenase (TDO2) and Indoleamine 2,3-Dioxygenase 1 (IDO1) Using Virtual Screening.
    Sari S; Tomek P; Leung E; Reynisson J
    Molecules; 2019 Nov; 24(23):. PubMed ID: 31795096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumour agents as inhibitors of tryptophan 2,3-dioxygenase.
    Pantouris G; Mowat CG
    Biochem Biophys Res Commun; 2014 Jan; 443(1):28-31. PubMed ID: 24269239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fused Heterocyclic Compounds as Potent Indoleamine-2,3-dioxygenase 1 Inhibitors.
    Panda S; Roy A; Deka SJ; Trivedi V; Manna D
    ACS Med Chem Lett; 2016 Dec; 7(12):1167-1172. PubMed ID: 27994758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and Molecular Modeling Studies of N'-Hydroxyindazolecarboximidamides as Novel Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors.
    Lee DH; Lee JY; Jeong J; Kim M; Lee KW; Jang E; Ahn S; Lee CH; Hwang JY
    Molecules; 2017 Nov; 22(11):. PubMed ID: 29120388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting TDO in cancer immunotherapy.
    Yu CP; Song YL; Zhu ZM; Huang B; Xiao YQ; Luo DY
    Med Oncol; 2017 May; 34(5):73. PubMed ID: 28357780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of indoleamine 2,3-dioxygenase-mediated cancer immune suppression by systemic kynurenine depletion with a therapeutic enzyme.
    Triplett TA; Garrison KC; Marshall N; Donkor M; Blazeck J; Lamb C; Qerqez A; Dekker JD; Tanno Y; Lu WC; Karamitros CS; Ford K; Tan B; Zhang XM; McGovern K; Coma S; Kumada Y; Yamany MS; Sentandreu E; Fromm G; Tiziani S; Schreiber TH; Manfredi M; Ehrlich LIR; Stone E; Georgiou G
    Nat Biotechnol; 2018 Sep; 36(8):758-764. PubMed ID: 30010674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of indoleamine-2,3-dioxigenase 1 inhibitory activity of 4,6-disubstituted indazole derivatives and their heme binding affinity.
    Tsujino H; Uno T; Yamashita T; Katsuda M; Takada K; Saiki T; Maeda S; Takagi A; Masuda S; Kawano Y; Meguro K; Akai S
    Bioorg Med Chem Lett; 2019 Oct; 29(19):126607. PubMed ID: 31431359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of selective inhibitors of indoleamine 2,3-dioxygenase 2.
    Bakmiwewa SM; Fatokun AA; Tran A; Payne RJ; Hunt NH; Ball HJ
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7641-6. PubMed ID: 23122865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computational study on new natural compound inhibitors of indoleamine 2,3-dioxygenase 1.
    Jiang S; Li H; Piao L; Jin Z; Liu J; Chen S; Liu LL; Shao Y; Zhong S; Wu B; Li W; Ren J; Zhang Y; Wang H; Jin R
    Aging (Albany NY); 2020 Jun; 12(12):11349-11363. PubMed ID: 32568737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.